Alpha Teknova (TKNO) Common Equity (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Common Equity of $64.9 million for Q1 2026, down 17.4% year-over-year from $78.6 million in Q1 2025, and down 5.6% quarter-over-quarter from $68.8 million in Q4 2025.
Alpha Teknova (TKNO) Common Equity (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Common Equity for 7 consecutive years, with $64.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 17.4% year-over-year to $64.9 million; the TTM figure through Mar 2026 stood at $64.9 million (down 17.4% YoY), while the FY2025 annual figure was $68.8 million, down 16.53% from the prior year.
- Common Equity fell to $64.9 million in Q1 2026 per TKNO's latest filing, from $68.8 million in the prior quarter.
- Across five years, Common Equity topped out at $138.5 million in Q1 2022 and bottomed at $64.9 million in Q1 2026.
- Historically, Common Equity has averaged $90.9 million across 5 years, with a median of $86.2 million in 2023.
- Annual changes were most pronounced in 2022 — Common Equity soared 843.92% — and 2023, when it plunged 35.41%.
- Alpha Teknova's Common Equity stood at $99.9 million in 2022, then decreased by 9.86% to $90.0 million in 2023, then decreased by 8.49% to $82.4 million in 2024, then retreated by 16.53% to $68.8 million in 2025, then slipped by 5.6% to $64.9 million in 2026.
- Business Quant data shows TKNO's Common Equity at $64.9 million in Q1 2026, $68.8 million in Q4 2025, and $72.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | 62.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.60 Mn |
| Mar 31, 2026 | 64.92 Mn |
| Dec 31, 2025 | 68.78 Mn |
| Sep 30, 2025 | 72.65 Mn |
| Jun 30, 2025 | 76.06 Mn |
| Mar 31, 2025 | 78.61 Mn |
| Dec 31, 2024 | 82.39 Mn |
| Sep 30, 2024 | 87.27 Mn |
| Jun 30, 2024 | 78.93 Mn |
| Mar 31, 2024 | 83.38 Mn |
| Dec 31, 2023 | 90.04 Mn |
| Sep 30, 2023 | 99.65 Mn |
| Jun 30, 2023 | 86.21 Mn |
| Mar 31, 2023 | 92.09 Mn |
| Dec 31, 2022 | 99.89 Mn |
| Sep 30, 2022 | 112.00 Mn |
| Jun 30, 2022 | 133.47 Mn |
| Mar 31, 2022 | 138.55 Mn |
| Dec 31, 2021 | 143.20 Mn |
| Sep 30, 2021 | 146.23 Mn |